pmid,title,journal,year,drug,disease
37592236,"The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.",Cardiovascular diabetology,2023,Dasatinib,Non-alcoholic Fatty Liver Disease
36142384,"Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation.",International journal of molecular sciences,2022,Dasatinib,Non-alcoholic Fatty Liver Disease
33832488,Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin.,Cell communication and signaling : CCS,2021,Dasatinib,Non-alcoholic Fatty Liver Disease
33144268,"Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?",Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft,2021,Dasatinib,Non-alcoholic Fatty Liver Disease
30425964,Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer.,Frontiers in oncology,2018,Dasatinib,Non-alcoholic Fatty Liver Disease
28608850,Cellular senescence drives age-dependent hepatic steatosis.,Nature communications,2017,Dasatinib,Non-alcoholic Fatty Liver Disease
